Braslyn Ltd. - Net Worth and Insider Trading
Braslyn Ltd. Net Worth
The estimated net worth of Braslyn Ltd. is at least $190 Million dollars as of 2025-04-13. Braslyn Ltd. is the 10% Owner of Mirati Therapeutics Inc and owns about 3,135,966 shares of Mirati Therapeutics Inc (MRTX) stock worth over $184 Million. Braslyn Ltd. is also the 10% Owner of Inseego Corp and owns about 761,483 shares of Inseego Corp (INSG) stock worth over $6 Million. Details can be seen in Braslyn Ltd.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Braslyn Ltd. has not made any transactions after 2021-03-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Braslyn Ltd.
Braslyn Ltd. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Braslyn Ltd. owns 6 companies in total, including Pandion Therapeutics Inc (PAND) , Mirati Therapeutics Inc (MRTX) , and Inseego Corp (INSG) among others .
Click here to see the complete history of Braslyn Ltd.’s form 4 insider trades.
Insider Ownership Summary of Braslyn Ltd.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PAND | Pandion Therapeutics Inc | 2020-07-21 | 10 percent owner |
| MRTX | Mirati Therapeutics Inc | 2021-03-10 | 10 percent owner |
| INSG | Inseego Corp | 2020-12-16 | 10 percent owner |
 | | 2019-03-04 | 10 percent owner |
| | 2018-10-26 | 10 percent owner |
| | 2021-08-10 | 10 percent owner |
Braslyn Ltd. Latest Holdings Summary
Braslyn Ltd. currently owns a total of 2 stocks. Among these stocks, Braslyn Ltd. owns 3,135,966 shares of Mirati Therapeutics Inc (MRTX) as of March 10, 2021, with a value of $184 Million and a weighting of 97.08%. Braslyn Ltd. also owns 761,483 shares of Inseego Corp (INSG) as of December 16, 2020, with a value of $6 Million and a weighting of 2.92%.
Latest Holdings of Braslyn Ltd.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MRTX | Mirati Therapeutics Inc | 2021-03-10 | 3,135,966 | 58.70 | 184,081,204 |
| INSG | Inseego Corp | 2020-12-16 | 761,483 | 7.26 | 5,528,367 |
Holding Weightings of Braslyn Ltd.
Braslyn Ltd. Form 4 Trading Tracker
According to the SEC Form 4 filings, Braslyn Ltd. has made a total of 4 transactions in Mirati Therapeutics Inc (MRTX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Mirati Therapeutics Inc is the sale of 12,381 shares on March 10, 2021, which brought Braslyn Ltd. around $2 Million.
According to the SEC Form 4 filings, Braslyn Ltd. has made a total of 1 transactions in Inseego Corp (INSG) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Inseego Corp is the sale of 238,517 shares on December 16, 2020, which brought Braslyn Ltd. around $37 Million.
Insider Trading History of Braslyn Ltd.
- 1
Braslyn Ltd. Trading Performance
GuruFocus tracks the stock performance after each of Braslyn Ltd.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Braslyn Ltd. is -39.64%. GuruFocus also compares Braslyn Ltd.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Braslyn Ltd. within 3 months outperforms 0 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Braslyn Ltd.'s insider trading performs compared to the benchmark.
Performance of Braslyn Ltd.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.9 | | | | | |
| Relative Return to S&P 500(%) | -3.94 | | | | | |
Braslyn Ltd. Ownership Network
Ownership Network List of Braslyn Ltd.
Ownership Network Relation of Braslyn Ltd.
Braslyn Ltd. Owned Company Details
What does Pandion Therapeutics Inc do?
Who are the key executives at Pandion Therapeutics Inc?
Braslyn Ltd. is the 10 percent owner of Pandion Therapeutics Inc. Other key executives at Pandion Therapeutics Inc include director & 10 percent owner Daniel J. Becker , 10 percent owner Boxer Capital, Llc , and 10 percent owner Polaris Partners VIII, L.P. .
Pandion Therapeutics Inc (PAND) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Pandion Therapeutics Inc (PAND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pandion Therapeutics Inc (PAND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Pandion Therapeutics Inc (PAND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pandion Therapeutics Inc Insider Transactions
Braslyn Ltd. Mailing Address
Above is the net worth, insider trading, and ownership report for Braslyn Ltd.. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Braslyn Ltd.'s mailing address is: New Providence C5 00000.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
